Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
A pharmaceutical company in San Francisco has announced a pilot study of a GLP-1 drug for cats with obesity
Carnitine deficiency impairs the mitochondrial -oxidation of FAs, leading to acute metabolic decompensation, elevated aminotransferase, and hepatic encephalopathy similar to NAFLD (75)
Offer valid January 4, 2026 while supplies last
Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed severe threats to human health, public safety, and the global economy
They can help generate hypotheses and guide more rigorous, controlled research that allows us to draw more definitive conclusions.
US$ 24.01
US$ 27.17
US$ 23.21
US$ 24.88
